Intercept Pharmaceuticals reported $85.12M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 168.21M 60.27M
Acorda Therapeutics ACOR:US $ 44.97M 5.73M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Amarin AMRN:US 157.27M 34.34M
Amgen AMGN:US $ 4.42B 680M
Arrowhead Research ARWR:US $ 105.32M 4.93M
AstraZeneca AZN:LN 840.42B 39.99B
Biogen BIIB:US $ 2648.2M 727.1M
Bluebird Bio BLUE:US $ 108.92M 13.37M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Enanta Pharmaceuticals ENTA:US $ 52.02M 544K
Esperion Therapeutics ESPR:US $ 71.22M 9.39M
Galectin Therapeutics GALT:US $ 9.66M 273K
Gilead Sciences GILD:US $ 4231M 2162M
GlaxoSmithKline GSK:LN 584.8B 95.1B
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
IONIS PHARMACEUT IONS:US $ 219.3M 19.88M
Moderna Inc MRNA:US 2.3B 463M
Neurocrine Biosciences NBIX:US $ 393.5M 86M
Novartis NOVN:VX 10.86B 895M
Ptc Therapeutics PTCT:US $ 257.89M 22.63M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Sangamo Biosciences SGMO:US $ 75.11M 1.62M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
YTE INCY:US $ 656.97M 40.27M